Medication info

Zagutex Neo Syrup (Amoxicillin Hydrate - Potassium Clavulanate)

Prescription medicationSyrupOral
Ingredient · strength
Amoxicillin Hydrate›54.545g / 100gDilute Potassium Clavulanate›7.8g / 100g
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
A syrup formulation as a white or pale yellow powder that is dissolved before use.
Packaging
50 mL/bottle
Approval status
Active

MFDS item code 201405931 · Notified 2014.12.18 · Insurance code 698502901

Summary

Main use
Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children
Who takes it
Adults · Children
Adult dose
○ Adults: There is no experience with the use of this drug in adults. ○ Patients with hepatic impairment: Caution should be exercised when administering this drug to patients with hepatic impairment, and liver function should be monitored regularly. ○ To minimize the possibility of gastrointestinal disturbances, administer this drug at the beginning of a meal. Administration of this drug at the beginning of a meal increases the absorption of potassium clavulanate.
Child dose
○ Pediatric patients aged 3 months and older: The recommended dose of this drug, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day, divided into doses every 12 hours. Administer for 10 days for acute otitis media and for 7 days for acute sinusitis. 8kg: Administer 3.0mL every 12 hours 12kg: Administer 4.5mL every 12 hours 16kg: Administer 6.0mL every 12 hours 20kg: Administer 7.5mL every 12 hours 24kg: Administer 9.0mL every 12 hours 28kg: Administer 10.5mL every 12 hours 32kg: Administer 12.0mL every 12 hours 36kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this drug in pediatric patients weighing 40kg or more.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children

  • Recurrent acute otitis media
  • persistent acute otitis media
  • recurrent acute sinusitis
View approved original text

This medication is effective primarily against major bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. It is especially used for children under 2 years old or those attending daycare, with recurrent or persistent acute otitis media or acute sinusitis after receiving antibiotic treatment within the last three months. It effectively treats recurrent or persistent acute otitis media and acute sinusitis in pediatric patients with these conditions. Therefore, this drug helps safely treat otitis media and sinusitis in children.

How to take

Adult dose

○ Adults: There is no experience with the use of this drug in adults. ○ Patients with hepatic impairment: Caution should be exercised when administering this drug to patients with hepatic impairment, and liver function should be monitored regularly. ○ To minimize the possibility of gastrointestinal disturbances, administer this drug at the beginning of a meal. Administration of this drug at the beginning of a meal increases the absorption of potassium clavulanate.

Child dose

○ Pediatric patients aged 3 months and older: The recommended dose of this drug, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day, divided into doses every 12 hours. Administer for 10 days for acute otitis media and for 7 days for acute sinusitis. 8kg: Administer 3.0mL every 12 hours 12kg: Administer 4.5mL every 12 hours 16kg: Administer 6.0mL every 12 hours 20kg: Administer 7.5mL every 12 hours 24kg: Administer 9.0mL every 12 hours 28kg: Administer 10.5mL every 12 hours 32kg: Administer 12.0mL every 12 hours 36kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this drug in pediatric patients weighing 40kg or more.

Precautions

This medication is a penicillin-type antibiotic that contains both amoxicillin and clavulanate for treating bacterial infections. It should not be administered to patients with a hypersensitivity reaction to beta-lactam agents, and caution is necessary for patients with infectious mononucleosis or lymphocytic leukemia due to the risk of rash. Patients with a history of liver dysfunction or jaundice caused by this medication or penicillin should avoid its use due to a risk of recurrence. Since it contains lactose, patients with lactose intolerance or related genetic disorders should not take it. In patients with impaired liver or kidney function, the drug concentration may increase, so careful administration or dosage adjustment is necessary. Patients with an allergic constitution or those who experienced symptoms such as bronchial asthma, rash, or urticaria should use this medication cautiously. Gastrointestinal symptoms may include diarrhea, vomiting, abdominal pain, and in some cases, severe colitis or pancreatitis may occur; therefore, immediate consultation with medical personnel is required if abnormal symptoms arise. Liver function abnormalities may occur, which require increased caution, especially in the elderly or with prolonged use. Rarely, severe skin reactions or hypersensitivity reactions such as anaphylaxis may occur, so if rash, itching, or difficulty breathing occurs, immediate discontinuation and medical treatment are necessary. Blood-related abnormalities, such as leukopenia, anemia, and thrombocytopenia, have been reported, so testing is required if abnormal symptoms appear. It may affect the central nervous system, causing anxiety, restlessness, dizziness, headache, and rarely seizures; caution is needed particularly in patients with poor kidney function. This medication can affect the intestinal microbiome, influencing other infections or drug effectiveness, so monitoring is necessary with prolonged use. Pregnant or breastfeeding individuals should avoid using this medication during early pregnancy due to safety not being fully established and should discontinue if abnormal symptoms occur in infants during nursing. It is not used in infants under 3 months of age as safety and efficacy have not been confirmed. This medication may affect some urine test results, so caution is needed during testing. In cases of overdose, gastrointestinal symptoms, kidney problems, seizures, etc., may occur, so immediate contact with medical personnel for appropriate treatment is essential. This medication should be used according to the prescribed dosage and duration, and should not be discontinued arbitrarily even if symptoms improve during treatment.

Side effects

Contact dermatitis, diaper rash, diarrhea, vomiting, moniliasis, rash, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, anorexia, abdominal pain, abdominal distension, constipation, colonic pain, acid reflux, diarrhea, dry mouth, acute pancreatitis, candidiasis, antibiotic-induced colitis, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized exanthematous pustulosis, eosinophilia, drug reaction (DRESS), angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, reversible leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, burning sensation, increased discharge, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, seizures, aseptic meningitis, acute kidney failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B group deficiency, tooth discoloration, linear IgA disease, taste disturbance, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, hyperactivity, drowsiness, interstitial nephritis, oliguric kidney failure, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. Additionally, it should be kept in a cool, dry place below 25 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

A syrup formulation as a white or pale yellow powder that is dissolved before use.

Package unit

50 mL/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.